Coloplast As Stock Today
| CLPBF Stock | USD 128.57 7.42 6.12% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Coloplast A/S is trading at 128.57 as of the 28th of November 2024. This is a 6.12 percent up since the beginning of the trading day. The stock's lowest day price was 127.8. Coloplast A/S has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Coloplast AS are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of December 2022 and ending today, the 28th of November 2024. Click here to learn more.
Coloplast AS engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. Coloplast AS was founded in 1954 and is headquartered in Humlebk, Denmark. Coloplast is traded on OTC Exchange in the United States.. The company has 194.31 M outstanding shares. More on Coloplast AS
Moving against Coloplast Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Coloplast Pink Sheet Highlights
| President | Alain Morvan |
| Business Concentration | Medical Instruments & Supplies, Healthcare (View all Sectors) |
Coloplast AS [CLPBF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Large-Cap' category with a current market capitalization of 24.87 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Coloplast A/S's market, we take the total number of its shares issued and multiply it by Coloplast A/S's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Coloplast A/S classifies itself under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 194.31 M outstanding shares.
Coloplast AS has accumulated about 854 M in cash with 5.1 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.02.
Check Coloplast A/S Probability Of Bankruptcy
Ownership AllocationColoplast A/S holds a total of 194.31 Million outstanding shares. Coloplast AS retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Coloplast Ownership Details
Coloplast A/S Risk Profiles
| Mean Deviation | 0.6941 | |||
| Standard Deviation | 1.47 | |||
| Variance | 2.17 | |||
| Risk Adjusted Performance | (0.04) |
Coloplast Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Coloplast A/S without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Backtesting Now
Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios |
| All Next | Launch Module |
Other Information on Investing in Coloplast Pink Sheet
Coloplast A/S financial ratios help investors to determine whether Coloplast Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Coloplast with respect to the benefits of owning Coloplast A/S security.